BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21055516)

  • 1. [Sentinel lymph node and neoadjuvant therapy in breast cancer: searching for the best scenario].
    Solá M; Fraile M
    Rev Esp Med Nucl; 2010; 29(6):316-8. PubMed ID: 21055516
    [No Abstract]   [Full Text] [Related]  

  • 2. [Sentinel lymph node and neoadjuvant therapy in breast cancer].
    Muñoz M; Pahisa J; Xavier Caparrós F; Vidal-Sicart S
    Rev Esp Med Nucl; 2010; 29(6):319-20. PubMed ID: 21055517
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of sentinel node biopsy in patients having neoadjuvant chemotherapy.
    Dixon JM; Cody HS
    Eur J Surg Oncol; 2010 Jun; 36(6):511-3. PubMed ID: 20488645
    [No Abstract]   [Full Text] [Related]  

  • 4. Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer (Br J Surg 2006: 93: 539-546).
    Gui G
    Br J Surg; 2006 Aug; 93(8):1025-6; author reply 1026. PubMed ID: 16845702
    [No Abstract]   [Full Text] [Related]  

  • 5. Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy.
    Lambert LA; Ayers GD; Meric-Bernstam F
    Ann Surg Oncol; 2007 Aug; 14(8):2422-3. PubMed ID: 17514406
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of sentinel node biopsy before and after neoadjuvant chemotherapy: timing is important.
    Jones JL; Zabicki K; Christian RL; Gadd MA; Hughes KS; Lesnikoski BA; Rhei E; Specht MC; Dominguez FJ; Smith BL
    Am J Surg; 2005 Oct; 190(4):517-20. PubMed ID: 16164912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel node identification rate, but not accuracy, is significantly decreased after pre-operative chemotherapy in axillary node-positive breast cancer patients.
    Lee S; Kim EY; Kang SH; Kim SW; Kim SK; Kang KW; Kwon Y; Shin KH; Kang HS; Ro J; Lee ES
    Breast Cancer Res Treat; 2007 May; 102(3):283-8. PubMed ID: 17063280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A decade of sentinel lymph node biopsy for breast cancer: time for adaptations].
    Wobbes T
    Ned Tijdschr Geneeskd; 2008 Jan; 152(1):10-2. PubMed ID: 18240753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Frozen section exam value in breast cancer].
    Chifu C; Diaconu C
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(3):771-9. PubMed ID: 20191831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of sentinel node-positive breast cancer.
    Chagpar AB; McMasters KM
    Expert Rev Anticancer Ther; 2006 Aug; 6(8):1233-9. PubMed ID: 16925489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast conservation and sentinel lymph node biopsy after neoadjuvant systemic therapy.
    Veronesi P; Gentilini O; Fernandez JR; Magnoni F
    Breast; 2009 Oct; 18 Suppl 3():S90-2. PubMed ID: 19914551
    [No Abstract]   [Full Text] [Related]  

  • 12. Sentinel lymph node mapping and biopsy for ductal carcinoma in situ and other controversial indications.
    Fuhrman GM
    Am Surg; 2004 May; 70(5):403-6. PubMed ID: 15156947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraoperative imprint cytology examination of sentinel lymph nodes after neoadjuvant chemotherapy in breast cancer patients.
    Gimbergues P; Dauplat MM; Durando X; Abrial C; Le Bouedec G; Mouret-Reynier MA; Cachin F; Kwiatkowski F; Tchirkov A; Dauplat J; Penault-Llorca F
    Ann Surg Oncol; 2010 Aug; 17(8):2132-7. PubMed ID: 20155400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.
    Reitsamer R; Peintinger F; Rettenbacher L; Prokop E
    J Surg Oncol; 2003 Oct; 84(2):63-7. PubMed ID: 14502778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer.
    Xing Y; Foy M; Cox DD; Kuerer HM; Hunt KK; Cormier JN
    Br J Surg; 2006 May; 93(5):539-46. PubMed ID: 16329089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological factors and nomograms predicting nonsentinel lymph node metastases after neoadjuvant chemotherapy in breast cancer patients.
    Gimbergues P; Abrial C; Durando X; Le Bouedec G; Cachin F; Penault-Llorca F; Mouret-Reynier MA; Kwiatkowski F; Maublant J; Tchirkov A; Dauplat J
    Ann Surg Oncol; 2009 Jul; 16(7):1946-51. PubMed ID: 19408057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower nodal counts in axillary dissection following neoadjuvant chemotherapy: are there implications?
    Callcut RA; Breslin TM
    Am J Surg; 2006 Jun; 191(6):830-1. PubMed ID: 16720160
    [No Abstract]   [Full Text] [Related]  

  • 18. Controversies in the use of sentinel nodes: microinvasion, post surgery and after preoperative systemic treatment.
    Veronesi P; Rodriguez-Fernandez J; Intra M
    Breast; 2007 Dec; 16 Suppl 2():S67-70. PubMed ID: 17697779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can breast MRI predict axillary lymph node metastasis in women undergoing neoadjuvant chemotherapy.
    Javid S; Segara D; Lotfi P; Raza S; Golshan M
    Ann Surg Oncol; 2010 Jul; 17(7):1841-6. PubMed ID: 20143266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel lymph node biopsy in women with pT1a or "microinvasive" breast cancer.
    Fortunato L; Santoni M; Drago S; Gucciardo G; Farina M; Cesarini C; Cabassi A; Tirelli C; Terribile D; Grassi GB; De Fazio S; Vitelli CE;
    Breast; 2008 Aug; 17(4):395-400. PubMed ID: 18468896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.